Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIM811 in relapsed chronic hepatitis C genotype-1
NCT00983060Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- Apr 2011
- Countries
- 7
01
Overview
A Phase 2 trial of NIM811 in chronic hepatitis C virus infection, sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
NIM811
03
Conditions
chronic hepatitis C virus infection
Beyond the preview
Go deeper on NCT00983060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983060.